Page 44 - TD-3-1
P. 44

Tumor Discovery                                                        Energy metabolism in bladder cancer




                         A                                   B
















                         C                                     D

















                         E                                    F




















            Figure 4. Representative immunoblotting analysis results and semi-quantitative determination of β-F1-ATP synthase (ATPase) (A), HADHSC (B), PDH
            (C), CS (D), GLUT 1 (E), and PFK (F) protein levels. Representative protein profiles pooled from ten patients per group for each repetition (duplicate).
            Graphs depict the relative expression of integrated optical density observed for β-F1-ATP synthase (ATPase), HADHSC, PDH, CS, GLUT 1, and PFK
            proteins, normalized by β-actin and expressed as mean ± standard deviation. *Significance difference (P < 0.01), after applying Tukey test.
            Abbreviations: ATP: Adenosine triphosphate; GLUT1: Glucose transporter-1; PFK: Phosphofructokinase; PDH: Pyruvate dehydrogenase; CS: Citrate
            synthase; HADHSC: Short chain 3-hydroxyacyl-CoA dehydrogenase.

            and low-grade pTa tumors recorded notably higher IBEC   allows removing visible lesions and collecting tissue
            values than both high-grade pTa and pT1 tumors, as   samples for histopathological  analysis  purposes,  and it
            graphically represented in Figure 7.               enables determining tumor stage and grade. Intravesical
                                                               chemotherapy is often administered as adjunctive measure
            4. Discussion                                      for NMIBC treatment within 6 h after TURBT to prevent

            The primary treatment approach to NMIBC typically   tumor cells’ post-procedure implantation and to reduce
            involves surgical intervention via TURBT. This procedure   relapse rates.  Another adjuvant therapy option is BCG
                                                                         24

            Volume 3 Issue 1 (2024)                         8                          https://doi.org/10.36922/td.2290
   39   40   41   42   43   44   45   46   47   48   49